Tomoaki Yamanoi
Papers
2
Total Citations
10
H-Index
2
About
Dr. Tomoaki Yamanoi is a pioneering urologic surgeon whose research focuses on advancing minimally invasive treatments for renal cell carcinoma and complex kidney disorders. His work centers on two key areas: comparing the efficacy of robot-assisted partial nephrectomy against image-guided percutaneous cryoablation for cT1 renal cell carcinoma, and developing robot-assisted kidney autotransplantation (RAKAT) as a less invasive alternative to traditional open surgery. In his 2024 propensity score-matched analysis, Dr. Yamanoi demonstrated that both techniques offer comparable oncologic outcomes for small renal tumors, providing crucial evidence for treatment selection. His comprehensive literature review on RAKAT, also published in 2024, establishes this procedure as a promising minimally invasive option for complex conditions like renal artery aneurysms and ureteral injuries, potentially reducing recovery times and surgical trauma. Though his most-cited papers currently have 5 citations each, their recent publication in 2024 suggests growing recognition of his contributions. Dr. Yamanoi’s work is particularly notable for systematically evaluating emerging technologies against established standards, helping to define best practices in nephron-sparing surgery and advancing the frontier of robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2